SCHEMBL19064473

SCHEMBL19064473

Oc1c(-c2c(F)cc(Br)c3ccccc23)ccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN22 Q9Y2R2 1/20 0.41
▸ RCE1 Q9Y256 1/20 0.40
▸ DHFR P00374 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ HPRT1 P00492 1/20 0.38
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ NFKB1 P19838 2/20 0.37
▸ NFKB2 Q00653 2/20 0.37
▸ RELA Q04206 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080434 0.82 CYP1A2 (0.41) DHFRPOLBMEN1KMT2AMAPT
SCHEMBL19080430 0.80 POLB (0.47) PTPN22POLBMEN1KMT2AMAPT
SCHEMBL19063385 0.80 PTPN22 (0.42) PTPN22RCE1DHFRPOLBMEN1
SCHEMBL19063380 0.78 MAPT (0.38) POLBMEN1KMT2AMAPTKDM4E
SCHEMBL18263196 0.78 PTPN22 (0.40) PTPN22DHFRPOLBMEN1KMT2A
SCHEMBL19063374 0.76 RCE1 (0.38) RCE1POLBMEN1KMT2AMAPT
SCHEMBL19543873 0.75 ALDH1A1 (0.51) PTPN22DHFRPOLBMEN1KMT2A
SCHEMBL16067549 0.75 NMUR2 (0.51) PTPN22RCE1DHFRPOLBMEN1
SCHEMBL19064466 0.74 HPRT1 (0.39) RCE1POLBMAPTALDH1A1HPRT1
SCHEMBL19080431 0.74 CYP1A2 (0.42) MEN1KMT2AMAPTALDH1A1HPRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 — — US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 — — US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 — — US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 PTPN22 4776/4885RCE1 925/4885DHFR 2162/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 PTPN22 4776/4885RCE1 925/4885DHFR 2162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback